Evaluation of serum antibody against Chlamydia pneumonia infection in patients with Chronic obstructive pulmonary disease in Tabriz hospitals

Authors

  • Abolfazl Jafari-Sales1 1- Dept. of Microbiology School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran. orcid http://orcid.org/0000-0002-5710-4076
  • Yashar Bagherizadeh 1
  • Raziyeh Helali-Pargali 1
  • Masood Khalifehpour 1
  • Nazila Imeni 2 2- Young Researchers and Elite Clube, Marand Branch, Islamic Azad University, Marand, Iran.
  • Behboud Jafari 3 3- Dept. of Microbiology, Ahar Branch, Islamic Azad University, Ahar, Iran.

DOI:

https://doi.org/10.22100/jkh.v13i4.2071

Keywords:

Chronic obstructive pulmonary disease, Chlamydia pneumonia, Antibody

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is the most common cause of death and disability due to pulmonary disease, in Which microbial agents has a significant role. Regarding the role of Chlamydia pneumonia infection in the initiation and development of COPD, this study aimed to evaluate the serum antibody level against C.pneumonia infection in patients with COPD in Tabriz hospitals in 2017.

Methods: In this descriptive cross-sectional study, 200 patients with COPD participated. Anti C.pneumoniae titers were determined by ELISA method. Statistical analysis was performed using SPSS software and T-test.

Results: The mean  IgG antibody was 73.94% and the mean IgM antibody was 0.955%. There was no association between sex with antibody level, smoker status, coronary artery stenosis, and anti-infectious antibodies to C.pneumoniae.

Conclusion: According to the results, although there was no significant correlation between C.pneumonia infection and COPD,  However, due to the importance of C.pneumoniae as a causative pathogen, it is recommended to use more specific methods, such as determining the presence of the bacterial genome in the case and control groups.

References

Kasper Dl, Braunwald E, Hauser S, Longo D, Larry Jameson J, Fauci A. Harrison's Principle of Internal Medicine, McGraw- Hill, 2005. 16th ed: 1547-1551.

Steven D, Shapiro MD, Gordon L, Snider MD, Stephen I, Rennard M. Chronic Brobchitis and Emphysema . Murray, Nadel, Mason, broaddus. Text book of respiratory medicine. Philadelphia. Elsevier Saunders, 2005.Vol 2; 4th ed: 1116-1127.

Amou A. Investigation of serum level ficolin-2 protein in patients with chronic obstro]uctive pulmonary disease (COPD). Medical Journal of Mashhad University of Medical Sciences 2017;60:469-76. [Persian].

MacNee W. Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 2008;177:820-9. doi:10.1164/rccm.200801-167UP

Buist AS, Vollmer WM. Smoking and other risk factors. Nadel J Murray J eds. Textbook of respiratory medicine, 2nd ed, Philadelphia WB Saunders; 1994: 1259-87.

Von Hertzen LC. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med 1998;30:27-37.

Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286S-91S.

Clementsen P, Permin H, Norn S. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 2002;12:73-9.

Papaetis GS, Anastasakou E, Tselou T, Karapanagiotou E, Botsis T, Roussou P, et al. Serological diagnosis of Chlamydophila pneumoniae infection in Greek COPD patients by microimmunofluorescence and ELISA. Med Sci Monit 2008;14:MT27-35.

Kensuke Sh, Maximilian W, Rachel JS, Lesley TC, Christiane S, Thomas AK, et al. The Genetic Transformation of Chlamydia pneumoniae. Rupp J 2018;3:1-16. doi:10.1128/mSphere.00412-18

Brooks GF, Carroll KC, Butel J, Morse SA, Mietzner TA. Jawetz, Melnick & Adelberg's Medical Microbiology.26 nd ed, USA (NY): McGraw-Hill; 2013.

Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, et al. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 2009;22:9-14. doi:10.1177/039463200902200102

Joshi R, Khandelwal B, Joshi D, Gupta OP. Chlamydophila pneumoniae infection and cardiovascular disease. N Am J Med Sci 2013;5:169-81. doi:10.4103/1947-2714.109178

Di Pietro M, Schiavoni G, Del Piano M, Shaik Y, Boscolo P, Caraffa A, et al. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. J Biol Regul Homeost Agents 2009;23:65-9.

Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004;72:1843-55.

Villegas E, Sorlozano A, Gutierrez J. Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives. J Med Microbiol 2010;59:1267-74. doi:10.1099/jmm.0.020362-0

Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000;181:S402-10. doi:10.1086/315596

Hafizi M, Imani-Rastabi R, Mousavi M, Karimi A. The prevalence of acute chlamydia pneumoniae infection in patients with acute exacerbation of the chronic obstructive pulmonary. J shahrekord univ Med sci 2013;15:93-100.

Zibaeenezhad MJ, Amanat A, Alborzi A, Obudi A. Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran. Angiology 2005;56:43-8. doi:10.1177/000331970505600106

Shirani S, Boroumand MA, Abbasi SH, Maghsoodi N, Shakiba M, Karimi A, et al. Preoperative carotid artery screening in patients undergoing coronary artery bypass graft surgery. Arch Med Res 2006;37:987-90. doi:10.1016/j.arcmed.2006.06.001

Stepien E, Pieniazek P, Branicka A, Bozek M. Chlamydia pneumoniaeinfections-diagnostic methods. Przegl Lek 2002;59:142-6.

Clementsen P, Permin H, Norn S. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 2002;12:73-9.

Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, et al. Serological evidence of association of a Novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infection. Lancet 1988;2:983-6.

Kuo CC, Campbell LA. Detection of Chlamydia pneumonia in Arterial Tissues. J Infect Dis 2000;181:S432-6. doi:10.1086/315615

Rubicz R, Zhu J, Laston S, Cole SA, Voruganti VS, Ebbesson SO, et al. Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study. Genet Epidemiol 2013;37:751-7. doi:10.1002/gepi.21745

Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing chlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada). Clin Infect Dis 2001;33:492-503. doi:10.1086/322632

Shokouhi S, Hajikhani B, Godazgar M, Samanabadi M, Sattari M, Jamaati HR, et al. Possible effect of Chlamydophila pneumoniae on COPD exacerbation. Tanaffos 2008;7:63-7.

Smieja M, Leigh R, Petrich A, Chong S, Kamada D, Hargreave FE, et al. Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis 2002;2:12. doi:10.1186/1471-2334-2-12

Yetkin G. Chlamydia pneumoniae and coronary artery disease: controversial results of serological studies. Int Immunopharmacol 2006;6:1524-5. doi:10.1016/j.intimp.2006.04.012

Miettinen H, Lehto S, Saikku P, Haffner SM, Rönnemaa T, Pyörälä K, et al. Association of chlamydia pneumoniae and acute coronary heart disase events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996;17:682-8.

Hoffmeister A, Rothenbacher D, Wanner P, Bode G, Persson K, Brenner H, et al. Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumonia,Systemic inflammation and stable coronary artery disease: negative results of a case-control study. J Am Coll Cardiol 2000;35:112-8.

Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Joint effects of Chlamydia pneumoniae infection and classic coronary risk factors on risk of acute myocardial infarction. Am Heart J 2003;146:324-30.

Danesh J, Whincup P, Walker M, Lennon LT, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. Br Med J 2000;321:208-13. doi:10.1136/bmj.321.7255.208

Sun YH, Pei WD, Wu YJ, Zhang J. Smoking increases the risk of coronary artery disease in Chinese with Chlamydia pneumoniae infection. Int J cardiol 2004;97:199-203. doi:10.1016/j.ijcard.2003.07.036

Published

2019-03-11

Issue

Section

Original Article(s)

How to Cite

Evaluation of serum antibody against Chlamydia pneumonia infection in patients with Chronic obstructive pulmonary disease in Tabriz hospitals. (2019). Knowledge and Health in Basic Medical Sciences, 13(4), 11-16. https://doi.org/10.22100/jkh.v13i4.2071

Most read articles by the same author(s)

<< < 47 48 49 50 51 52 53 54 55 56 > >>